Abstract:Vascular, Ahead of Print. ObjectivesPrevious research had shown that age, a positive family history, comorbidities, major surgical operations, gestation, and use of several medications could increase the incidence of venous thromboembolism (VTE). With the development of medical and clinical individualized treatment, many people exposed to above risk factors did not develop VTE, suggested that genetic factors are also involved in the development of VTE. In this review, we aim to summarize VTE diagnosis and treatment in pregnancy women related to gene polymorphism.MethodsA comprehensive electronic search using PubMed, MEDLINE, EMBASE and Web of Science was conducted to find relevant journal articles with key search terms including: "pregnancy OR pregnant," "venous thromboembolism OR VTE," "deep vein thrombosis OR DVT," "pulmonary embolism OR PE," and "genetic OR gene." Prominent publications from establishment of database till present were analysed to achieve a deeper understanding of VTE during pregnancy relate to genetic polymorphism, and the information was then collated to form this review.ResultsThe literature review revealed that inherited thrombophilia significantly associated with the development of VTE, especially the factor V Leiden (FVL) and prothrombin gene mutation (PGM). Furthermore, the role of methylenetetrahydrofolate reductase (MTHFR) gene mutation in the development of pregnancy-related VTE remains controversial, further study is required. In the present study, Marburg I polymorphism (G511 E), c.1538 G>A and c.1601 G>A in Factor V (FV), JAK2V617 F mutation were reported as an independent risk factor for VTE, there is no sufficient evidence to confirm the gene mutation is related to VTE during pregnancy, these factors appearing as another promising potential diagnostic marker of VTE during pregnancy. Besides, the dosages of heparin in the treatment of VTE during pregnancy need be adjusted according to gene polymorphism of these population, particularly FVL or PGM carriers, and this area is not studied deeply, it is worth further study.ConclusionInherited thrombophilia significantly associated with the development of VTE, especially the FVL and PGM, however the relation between MTHFR gene mutation and pregnancy-related VTE remains controversial, further study is needed. In addition, the dosages of heparin in the treatment of VTE during pregnancy suggested to adjusted based on gene polymorphism in FVL and PGM, and establish better prediction models is a direction of future research.

Venous thromboembolic disease in pregnancy:treatment, prevention and practice in China

A Brief Overview of a Round Table Discussion About Venous Thromboembolism in Pregnancy During the First International Forum on Chinese Maternal-Fetal Medicine

[Survey of Related Factors of Maternal Venous Thromboembolism in Nine Hospitals of China].

Trends in Hospitalization and In-Hospital Mortality from VTE, 2007 to 2016, in China

Risk factor assessment and management strategies for venous thromboembolism during pregnancy and puerperium

[The prevention, diagnosis and management of pregnancy-associated pulmonary embolism]

[Risk Factors and Therapeutic Strategies of Deep Venous Thrombosis During Pregnancy].

Venous Thromboembolism in Pregnancy: A Review of Diagnosis, Management, and Prevention

VTE risk assessment, prevention and diagnosis in pregnancy

Perioperative Intervention to Prevent Lower Extremity Deep Venous Thrombosis after Gynecologic Surgery

The radiological diagnosis of pregnancy associated venous thromboembolism: a review of current research

Venous thrombosis risk factors in pregnant women

Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period

Risk factors and prognosis analysis of venous thromboembolism in pregnancy and puerperium

Venous thromboembolism during pregnancy and postpartum period: an updated review

Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE—Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)

Clinical analysis of venous thromboembolic disease during puerperium

The diagnosis and treatment of pulmonary embolism during pregnancy

VTE Risk Assessment and Prevention in Pregnancy

Long-Term Outcome of Catheter-Directed Thrombolysis in Pregnancy-Related Venous Thrombosis

Diagnosis and treatment of venous thromboembolism during pregnancy relate to genetic polymorphism